Cargando…
Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management
Even though an approved vaccine for hepatitis B virus (HBV) is available and widely used, over 257 million individuals worldwide are living with chronic hepatitis B (CHB) who require monitoring of treatment response, viral activity, and disease progression to reduce their risk of HBV-related liver d...
Autores principales: | Vachon, Alicia, Osiowy, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224022/ https://www.ncbi.nlm.nih.gov/pubmed/34064049 http://dx.doi.org/10.3390/v13060951 |
Ejemplares similares
-
Hepatitis B virus serum RNA transcript isoform composition and proportion in chronic hepatitis B patients by nanopore long-read sequencing
por: Vachon, Alicia, et al.
Publicado: (2023) -
Characterization of Acute and Chronic Hepatitis B Virus Genotypes in Canada
por: Osiowy, Carla, et al.
Publicado: (2015) -
Novel biomarkers for the management of chronic hepatitis B
por: Inoue, Takako, et al.
Publicado: (2020) -
Hepatitis B Virus Genotype G: The Odd Cousin of the Family
por: Araujo, Natalia M., et al.
Publicado: (2022) -
Hepatitis B Virus Genotype Influence on Virological and Enzymatic Measures over Time—A Retrospective Longitudinal Cohort Study
por: Keeshan, Alexa, et al.
Publicado: (2023)